Mismatch repair protein MLH1 suppresses replicative stress in BRCA2-deficient breast tumors

Satheesh K Sengodan,Xiaoju Hu,Vaishnavi Peddibhotla,Kuppusamy Balamurugan,Alexander Y Mitrophanov,Lois McKennett,Suhas S Kharat,Rahul Sanawar,Vinod Kumar Singh,Mary E Albaugh,Sandra S Burkett,Yongmei Zhao,Bao Tran,Tyler Malys,Esta Sterneck,Subhajyoti De,Shyam K Sharan

DOI: https://doi.org/10.1172/JCI173718

2024-01-25

Abstract:Loss of BRCA2 (breast cancer 2) is lethal for normal cells. Yet it remains poorly understood how, in BRCA2 mutation carriers, cells undergoing loss of heterozygosity overcome the lethality and undergo tissue-specific neoplastic transformation. Here, we identified mismatch repair gene mutL homolog 1 (MLH1) as a genetic interactor of BRCA2 whose overexpression supports the viability of Brca2-null cells. Mechanistically, we showed that MLH1 interacts with Flap endonuclease 1 (FEN1) and competes to process the RNA flaps of Okazaki fragments. Together, they restrained the DNA2 nuclease activity on the reversed forks of lagging strands, leading to replication fork (RF) stability in BRCA2-deficient cells. In these cells, MLH1 also attenuated R-loops, allowing the progression of stable RFs, which suppressed genomic instability and supported cell viability. We demonstrated the significance of their genetic interaction by the lethality of Brca2-mutant mice and inhibition of Brca2-deficient tumor growth in mice by Mlh1 loss. Furthermore, we described estrogen as inducing MLH1 expression through estrogen receptor α (ERα), which might explain why the majority of BRCA2 mutation carriers develop ER-positive breast cancer. Taken together, our findings reveal a role of MLH1 in relieving replicative stress and show how it may contribute to the establishment of BRCA2-deficient breast tumors.